Cheyne Capital Management (UK)’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-26,200	Closed	-$234K	–	22
2023 Q3	$234K	Buy	+26,200	New	+$234K	0.68%	22
2023 Q1	–	Sell	-23,750	Closed	-$499K	–	48
2022 Q4	$499K	Buy	+23,750	New	+$499K	0.87%	38